middle.news
EZZ Life Science Surges with 16.6% Sales Growth and US Market Push
9:02am on Thursday 23rd of January, 2025 AEDT
•
Health Care
Read Story
EZZ Life Science Surges with 16.6% Sales Growth and US Market Push
9:02am on Thursday 23rd of January, 2025 AEDT
Key Points
Customer receipts rose 16.6% to $15.8 million in Q2 FY25
Operating cash flows increased 308% to $1.6 million
Four new products launched targeting evolving consumer health needs
Expanded retail presence with 14 new pharmacy listings in Australia
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Ezz Life Science (ASX:EZZ)
OPEN ARTICLE